Characterising the immune infiltrate of B and T cell dominated skin diseases to improve therapeutic options

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034344

Enrollment

Registered

2024-06-04

Start date

2022-02-03

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L63.0 L63.1 L63.2 L63.8

Interventions

Group 1: Patients 18+ years of age with the definite diagnosis of AA matching the specified clinical subtype / disease stage (AA totalis, AA universalis, Ophiasis, patch-type AA). Pregnant women and

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Definite diagnosis of alopecia areata with a defined clinical subtype.

Exclusion criteria

Exclusion criteria: Pregnancy.

Design outcomes

Primary

Measure	Time frame
Characterisation of the immune infiltrate in different subtypes of AA and adjacent non-lesional skin.	—

Secondary

Measure	Time frame
To identify predictive markers (ie. presence of certain immune cells) that can be used to predict therapy response.	—

Countries

Austria

Contacts

Public ContactJohannes Griss

Medizinische Universität Wien

johannes.griss@meduniwien.ac.at+43 1 40400 77020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026